Skip to content

Lenalidomide Impurity 36

Lenalidomide Impurity 36

Product Description
CAT No.
ALN-L031052
CAS No.
NA
Mol. F.
C25H33N3O13
Mol. Wt.
583.5
Stock
Please Inquire
RFQ
Chemical Name : 3-(1-oxo-4-(((3R,4R,E)-2,3,5,6-tetrahydroxy-4-(((2S,3R,4R,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexylidene)amino)isoindolin-2-yl)piperidine-2,6-dione
Smiles : O=C(C(N(CC1=C2C=CC=C1/N=C/C(O)[C@@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)C(CO)O3)C(O)CO)C2=O)CC4)NC4=O
Inchi : InChI=1S/C11H17NO2.ClH/c1-8-6-10(13-2)11(14-3)7-9(8)4-5-12;/h6-7H,4-5,12H2,1-3H3;1H

Determination of possible potential genotoxic impurities in lenalidomide drug substance by simple RP-HPLC method

By Gaddam, Kishore; Kanne, Shanker; Gundala, Trivikram Reddy; Mamilla, Yogeshwar Reddy; Chinna, Gangi Reddy NallagondunFrom Asian Journal of Chemistry (2020), 32(12), 2965-2970

Development and validation of stability-indicating RP-HPLC method for the estimation of lenalidomide and its impurities in oral solid dosage form

By Prasad, Somana Siva; Mohan, G. V. Krishna; Babu, A. Naga – From Oriental Journal of Chemistry (2019), 35(1), 140-149

Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: Application to a pharmacokinetic study

By Veeraraghavan, Sridhar; Viswanadha, Srikant; Thappali, Satheeshmanikandan; Govindarajulu, Babu; Vakkalanka, Swaroopkumar; Rangasamy, Manivannan – From Journal of Pharmaceutical and Biomedical Analysis (2015), 107, 151-158

Request For Quotation

Related Products